rs786204061
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM1PM4
The NM_000546.6(TP53):c.831_848dupTCCTGGGAGAGACCGGCG(p.Arg283_Thr284insProGlyArgAspArgArg) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. It is difficult to determine the true allele frequency of this variant because it is of type INS_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. R283R) has been classified as Likely benign.
Frequency
Consequence
NM_000546.6 disruptive_inframe_insertion
Scores
Clinical Significance
Conservation
Publications
- breast cancerInheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
- Li-Fraumeni syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Orphanet
- Li-Fraumeni syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp
- adrenocortical carcinoma, hereditaryInheritance: AD Classification: STRONG Submitted by: Ambry Genetics
- sarcomaInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- bone marrow failure syndrome 5Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- colorectal cancerInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- choroid plexus carcinomaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Li-Fraumeni syndrome Uncertain:1
In summary, this is a novel, in-frame duplication with uncertain impact on protein function. While this region of TP53 is important for DNA binding, the evidence is insufficient at this time to prove that this sequence change affects protein function or causes disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change inserts 18 nucleotides in exon 8 of the TP53 mRNA (c.831_848dupTCCTGGGAGAGACCGGCG). This leads to the insertion of 6 amino acid residues in the TP53 protein (p.Pro278_Arg283dup), but otherwise preserves the integrity of the reading frame. This sequence change has not been published in the literature and is not present in population databases. The 6 duplicated amino acid residues Pro278-Arg283 fall in the DNA binding domain of the TP53 protein (amino acids 102-292) (PMID: 8276238). Several missense substitutions at these six codons have been reported in affected patients (PMID: 10864200, 11370630, 15173255, 8688334) and have been shown experimentally to disrupt TP53 protein function (PMID: 17606709, 21343334). -
Hereditary cancer-predisposing syndrome Uncertain:1
The c.831_848dup18 variant (also known as p.P278_R283dup), located in coding exon 7 of the TP53 gene, results from an in-frame duplication of 18 nucleotides at nucleotide positions 831 to 848. This results in the duplication of 6 extra residues (PGRDRR) between codons 278 and 283. This amino acid region is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Based on the available evidence, the clinical significance of this variant remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at